albendazole has been researched along with Anterior Choroidal Artery Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coyle, CM | 1 |
| Weiss, LM | 1 |
| Rhodes, LV | 1 |
| Cali, A | 1 |
| Takvorian, PM | 1 |
| Brown, DF | 1 |
| Visvesvara, GS | 1 |
| Xiao, L | 1 |
| Naktin, J | 1 |
| Young, E | 1 |
| Gareca, M | 1 |
| Colasante, G | 1 |
| Wittner, M | 1 |
| Kohli, A | 1 |
| Gupta, R | 1 |
| Kishore, J | 1 |
2 other studies available for albendazole and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen.
Topics: Albendazole; Animals; Antibodies, Monoclonal; Antiprotozoal Agents; Antirheumatic Agents; Apansporob | 2004 |
Anterior cerebral artery territory infarction in neurocysticercosis: evaluation by MR angiography and in vivo proton MR spectroscopy.
Topics: Albendazole; Anthelmintics; Cerebral Arteries; Cerebral Infarction; Child; Contraindications; Cystic | 1997 |